A new daily low at $64.16 was just reached for $MRK.    #MRK
Small Cancer #Biotech Space in Focus, 3 #Stocks Up 100%+ - buff.ly/2s198et 
$AMGN $CELG $INCY $PFE $MRK $PBYI $BLUE $KITE $CLVS
3 Big Stock Charts for Thursday: $MRK $GILD and $VRX - http://investorplace.com/2017/06/3-big-stock-charts-for-thursday-merck-co-inc-mrk-gilead-sciences-inc-gild-and-valeant-pharmaceuticals-intl-inc-vrx/
$MRK Growth potential Up 18%
Forecast from Dominant investors app
Biogen‚Äôs Interferon Therapies Could Witness Modest Fall in 2017 http://marketrealist.com/?p=2171830 $BAYZF $BIIB $MRK $NVS $VUG
Merck &amp; Co. Inc.: The Bear Case from a Bull http://bit.ly/290617MRK $MRK $PFE
Spinraza May Significantly Boost Biogen‚Äôs Revenue Growth http://marketrealist.com/?p=2171852 $AMGN $BIIB $MRK $PFE $VHT
$MRK Cholesterol Drug Anacetrapib Meets Primary Endpoint https://t.co/Fy1cjJ2EHC $LLY $PFE
$MRK analysts on Estimize are expecting -5.43% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
@ccledez @TheGusFather I saw that. But their partnership with $MRK will be more long term outlook than Heplisav-B. I&#39;ll keep eye out, tho
Russia In The Spotlight As Second Wave Of Ransomware Grips Globe http://bit.ly/280617MSFT2 $MSFT $MRK
Tysabri Could Boost Biogen‚Äôs Revenue Growth http://marketrealist.com/?p=2171815 $BIIB $NVS $SNY $XLV $MRK
First Malignant Pleural Mesothelioma Patient Dosed in Phase 2 Trial of $ADRO &#39;s CRS-207 combined w/ $MRK &#39;s KEYTRUDA http://crweworld.com/article/press-releases/112763/aduro-biotech-announces-first-patient-dosed-in-phase-2-clinical-trial-of-crs-207-in-combination-with-keytruda-pembrolizumab-for-the-treatment-of-patients-with-previously-treated-malignant-pleural-mesothelioma
$HALO Reuters reports Good News https://www.reuters.com/article/brief-halozyme-phase-2-data-in-advanced-idUSFWN1JP0K0 $ANIP $AMGN $MRK
$VBIV, $VBV.CA, $GILD, $CTRV, $MRK, $BMY, $GSK Report Sees Hepatitis Drug Mrkt Reaching $70B by 2023 http://crweworld.com/newsroom/prnewswire?rkey=20170628IO28544&amp;filter=10284
Russia In The Spotlight As Second Wave Of Ransomware Grips Globe https://benzinga.com/z/9665914 $CYBR $FEYE $MRK $MSFT
$HALO News https://finance.yahoo.com/news/halozyme-phase-2-data-advanced-160000957.html $JNJ $BAX $MRK $LLY $
$MRK Petya Ransomware Attack: List of Companies Hit in Latest Hack via https://finzine.com
Esperion&#39;s Combo Cholesterol Candidate Enters Phase III http://bit.ly/2smpF8m $ESPR $REGN $MRK
Pfizer‚Äôs Segment Performance in 1Q17 http://marketrealist.com/?p=2162512 $PFE $HDV $LLY $MRK $JNJ
$MRK &#39;s CETP Inhibitor Anacetrapib Lowers Risk of Cardiac Events http://crweworld.com/article/markets/112566/mercks-cetp-inhibitor-lowers-risk-of-cardiac-events
Estimize revenue expectations are 0.17% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK cholesterol drug anacetrapib could serve as catalyst, Barron&#39;s reports http://bit.ly/2sfKln3
Computer Virus Spreads to U.S., Hits Merck - Report $MRK http://dlvr.it/PQZgXX
BMO Capital reiterated Merck &amp; $MRK at Buy. This 5yr DCF highlights discount https://t.co/TC4s3gyI4r https://t.co/X9dsJuw2U7
$MRK Better Buy: Eli Lilly and Co. vs. Merck &amp; Co., Inc. via https://finzine.com
Top Ten holdings of $XLB still looking pretty strong $JNJ $PFE $MRK $UNH $AMGN $MDT $ABBV $CELG $BMY and even $GILD
$MRK Can we profit from this? ü§∑üèª‚Äç‚ôÇÔ∏è What has become of me?! Lol. Shorting a company on bad news. Wall st. ü§¶üèª‚Äç‚ôÇÔ∏è
RECAP 6/27 Chatter
$MNK $KSS $RATE $TIME

RECAP 6/27 Positive
$CBI$FEYE $PANW $DECK

RECAP 6/27 Negative
$IRBT $PPC $FDX $MRK
@50kmollypercocet $MRK going up though lol.
$AGN hope we make a move on $AUPH before someone else buys them out. They&#39;re calling it the &quot;holy grail&quot; &amp;I already have a deal with $MRK
A new daily low at $64.16 was just reached for $MRK.    #MRK
Small Cancer #Biotech Space in Focus, 3 #Stocks Up 100%+ - buff.ly/2s198et 
$AMGN $CELG $INCY $PFE $MRK $PBYI $BLUE $KITE $CLVS
3 Big Stock Charts for Thursday: $MRK $GILD and $VRX - http://investorplace.com/2017/06/3-big-stock-charts-for-thursday-merck-co-inc-mrk-gilead-sciences-inc-gild-and-valeant-pharmaceuticals-intl-inc-vrx/
$MRK Growth potential Up 18%
Forecast from Dominant investors app
Biogen‚Äôs Interferon Therapies Could Witness Modest Fall in 2017 http://marketrealist.com/?p=2171830 $BAYZF $BIIB $MRK $NVS $VUG
Merck &amp; Co. Inc.: The Bear Case from a Bull http://bit.ly/290617MRK $MRK $PFE
Spinraza May Significantly Boost Biogen‚Äôs Revenue Growth http://marketrealist.com/?p=2171852 $AMGN $BIIB $MRK $PFE $VHT
$MRK Cholesterol Drug Anacetrapib Meets Primary Endpoint https://t.co/Fy1cjJ2EHC $LLY $PFE
$MRK analysts on Estimize are expecting -5.43% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
@ccledez @TheGusFather I saw that. But their partnership with $MRK will be more long term outlook than Heplisav-B. I&#39;ll keep eye out, tho
Russia In The Spotlight As Second Wave Of Ransomware Grips Globe http://bit.ly/280617MSFT2 $MSFT $MRK
Tysabri Could Boost Biogen‚Äôs Revenue Growth http://marketrealist.com/?p=2171815 $BIIB $NVS $SNY $XLV $MRK
First Malignant Pleural Mesothelioma Patient Dosed in Phase 2 Trial of $ADRO &#39;s CRS-207 combined w/ $MRK &#39;s KEYTRUDA http://crweworld.com/article/press-releases/112763/aduro-biotech-announces-first-patient-dosed-in-phase-2-clinical-trial-of-crs-207-in-combination-with-keytruda-pembrolizumab-for-the-treatment-of-patients-with-previously-treated-malignant-pleural-mesothelioma
$HALO Reuters reports Good News https://www.reuters.com/article/brief-halozyme-phase-2-data-in-advanced-idUSFWN1JP0K0 $ANIP $AMGN $MRK
$VBIV, $VBV.CA, $GILD, $CTRV, $MRK, $BMY, $GSK Report Sees Hepatitis Drug Mrkt Reaching $70B by 2023 http://crweworld.com/newsroom/prnewswire?rkey=20170628IO28544&amp;filter=10284
Russia In The Spotlight As Second Wave Of Ransomware Grips Globe https://benzinga.com/z/9665914 $CYBR $FEYE $MRK $MSFT
$HALO News https://finance.yahoo.com/news/halozyme-phase-2-data-advanced-160000957.html $JNJ $BAX $MRK $LLY $
$MRK Petya Ransomware Attack: List of Companies Hit in Latest Hack via https://finzine.com
Esperion&#39;s Combo Cholesterol Candidate Enters Phase III http://bit.ly/2smpF8m $ESPR $REGN $MRK
Pfizer‚Äôs Segment Performance in 1Q17 http://marketrealist.com/?p=2162512 $PFE $HDV $LLY $MRK $JNJ
$MRK &#39;s CETP Inhibitor Anacetrapib Lowers Risk of Cardiac Events http://crweworld.com/article/markets/112566/mercks-cetp-inhibitor-lowers-risk-of-cardiac-events
Estimize revenue expectations are 0.17% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK cholesterol drug anacetrapib could serve as catalyst, Barron&#39;s reports http://bit.ly/2sfKln3
Computer Virus Spreads to U.S., Hits Merck - Report $MRK http://dlvr.it/PQZgXX
BMO Capital reiterated Merck &amp; $MRK at Buy. This 5yr DCF highlights discount https://t.co/TC4s3gyI4r https://t.co/X9dsJuw2U7
$MRK Better Buy: Eli Lilly and Co. vs. Merck &amp; Co., Inc. via https://finzine.com
Top Ten holdings of $XLB still looking pretty strong $JNJ $PFE $MRK $UNH $AMGN $MDT $ABBV $CELG $BMY and even $GILD
$MRK Can we profit from this? ü§∑üèª‚Äç‚ôÇÔ∏è What has become of me?! Lol. Shorting a company on bad news. Wall st. ü§¶üèª‚Äç‚ôÇÔ∏è
RECAP 6/27 Chatter
$MNK $KSS $RATE $TIME

RECAP 6/27 Positive
$CBI$FEYE $PANW $DECK

RECAP 6/27 Negative
$IRBT $PPC $FDX $MRK
